Sandoz Canada is led by a diverse team with extensive experience in the pharmaceutical industry.
Michel Robidoux has been President and General Manager of Sandoz Canada since 2010. He has over 30 years of experience in the pharmaceutical and medical equipment industries.
Under his leadership, Sandoz Canada has grown to become one of the largest pharmaceutical companies in the country with more than 60 million prescriptions per year of generic and biosimilar products. Sandoz is among the Top 35 Employers in Montreal and among the Great Place to Work companies in the country.
Mr. Robidoux began his sales and marketing career at Bayer Canada for more than seven years and then held senior positions at Roche in the Diabetes Care, Clinical Diagnostics and Applied Science Divisions.
He is an active contributor to the Canadian pharmaceutical industry as a member of the Canadian Generic Pharmaceutical Association (CGPA), Chair of Biosimilar Canada and a member of the Board of Directors of the Canadian Association of Pharmaceutical Supply Management (CAPDM).
Mr. Robidoux holds a Bachelor degree in Business Administration from the Université du Québec in Montreal and has an A.S.C. (certified company administrator) designation from the Collège des administrateurs de sociétés of Université Laval.
Martin has more than 25 years of experience working for global organizations in the retail, medical devices and pharmaceutical industries. Before joining Sandoz Canada, he was Vice President, Diabetes & Cardiovascular business unit, at Sanofi Pharmaceutical, based in Montreal. He began his career with Glaxo Canada in Montreal and subsequently held senior positions, including in sales, account management and marketing, with such companies as Johnson & Johnson, Roche, Analogic Corporation and Bristol-Myers Squibb.
M. Arès holds a bachelor’s degree in Finance and Marketing from HEC Montréal and has also completed several professional development programs in finance, leadership and marketing, among others.
Jocelyn Binet has been Executive Director, Integrity and Compliance, Commercial Operations, since January 2018. Before joining Sandoz in 2017, he was Director of Inquiries and Syndic at the Ordre des pharmaciens du Québec. He also worked as a legal director, corporate secretary and legal consultant at Eli Lilly Canada.
Mr. Binet holds degrees in pharmacy and law
Mark Boehmer is Vice President Business Development, Portfolio & Launch Management since February 2017. He has worked in our industry for more than 25 years and is a pharmacist with hospital and community experience. He was most recently (since 2011) Vice President, Pharmaceutical Procurement, at the Katz Group, where he was responsible for managing the generic program for Rexall Pharmacy and gained a vast experience with Canadian pharmaceutical products.
Prior to Katz, M. Boehmer worked for several well-known pharmaceutical companies, including Merck Frosst Canada, Eli Lilly Canada and Schering Canada, before joining Patheon Inc. as Senior Manager, Pharmaceutical Development Services, in 1996. Over the following 15 years, he held increasingly senior positions with this leading global provider of outsourced drug development and manufacturing.
He holds a BSc (Chemistry) and Bachelor of Pharmacy from the University of Manitoba and an MBA from McMaster University, Michael G. DeGroote School of Business.
Martin Fournier has been Vice-President Finance and CFO since 2015. He is also in charge of business to business relations for Sandoz Canada since 2019. He joined Sandoz in 2006 as Director, Information and Financial Accounting. He has over 17 years of diverse project management experience in the field of accounting and finance, mainly within businesses in the manufacturing sector. Before joining Sandoz, he held various positions in accounting firms at the auditing and consulting levels, most recently at Deloitte as Senior Director, Management and Technology Consulting.
Mr. Fournier holds a Bachelor’s degree in Accounting, B.B.A., from Hautes Études Commerciales Montréal. He is also a member of the Ordre des comptables agréés du Québec.
Mauricio Ede is the Chief Medical & Scientific Officer and has been working for Sandoz Canada since February 2019. Cardiovascular surgeon and PhD in Physiology, Mauricio has more than 20 years of experience in health care in Canada and the United States. He has led scientific and regulatory teams in several pharmaceutical companies, including Merck Canada, Baxter and Abbott. He has lent his medical expertise and leadership to numerous product launches approved by regulatory authorities, including Health Canada, as well as to successful reimbursement efforts in Canadian provinces. He has also authored numerous scientific publications, mainly in the field of cardiovascular surgery.
Geneviève Giguère holds the position of Vice President, Supply Chain since March 2016. In this role, Ms. Giguère is responsible for supply chain operations, including demand management, procurement, distribution and customer service. She is also responsible for the relationship with our external partners to align strategies and execution with the various functions of the organization.
Prior to this role, Ms. Giguère held the position of Executive Director, Supply Chain from August 2015. Previously, she was Executive Director, Strategic Project Management, where she was responsible for business planning and the company’s strategic projects. She joined Sandoz from Deloitte Consulting where she managed projects for the healthcare industry, in various areas of the value chain such as logistics, procurement & sourcing and finance. She also developed strategies and performance management models for large organizations.
Genevieve holds a Bachelor degree in Industrial Engineering from École Polytechnique in Montreal, as well as an Executive MBA from Concordia University.
Karine Matteau leads the Biosimilar business segment and the growth of Sandoz’ portfolio of biosimilar products in various therapeutic fields. Ms. Matteau has over 20 years of experience in the pharmaceutical industry in various commercial strategic roles. She joined Novartis in 2007 and in the last 11 years, she has had a successful path through various commercial roles in multiple general medicine and specialty divisions. In her last mandates, she assumed leadership positions in Sales & Marketing within the Novartis Oncology division. Prior to Novartis, she held various commercial positions at Sanofi-Aventis Canada, mainly in CV & Metabolism/Diabetes.
Karine Matteau’s academic background includes an MBA from HEC Montreal and a Bachelor of Science from McGill University.
Isabelle Robitaille has been Vice President, Legal Affairs and General Counsel since January 2019.
Ms. Robitaille joined Sandoz in 2014 and is an expert in the fields of business and commercial law, mergers and acquisitions, and intellectual property rights.
She holds a Bachelor of Law from the Université de Sherbrooke and has 20 years of experience in transactional law, including more than 15 years in the pharmaceutical industry.
Marc St-Pierre holds the position of Vice President, People & Organization. His main responsibilities are to oversee the design and implementation of innovative programs focused on energy, development and job satisfaction in order to attract and retain the best talent, while ensuring policy alignment. He also leads the Communications team, which develops and implements communications plans intended for internal and external audiences in order to promote the reputation of Sandoz as a choice employer and industry leader in Canada.
Having joined Sandoz (previously Sabex) in 1997, Mr. St-Pierre has over 25 years' experience in the field of human resources management. He has previously held several management positions in industry-leading companies, more specifically in the publishing/direct mail business (with Reader's Digest) as well as telecommunications (with Canadian Marconi Company).
Mr. St-Pierre holds a Bachelor's degree in Industrial Relations from the Université du Québec en Outaouais and is a member of the Ordre des conseillers en ressources humaines agréés (CHRP).
Visit LinkedIn profile